Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06116136
Title	A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Servier Bio-Innovation LLC
Indications	gastroesophageal junction adenocarcinoma gastric adenocarcinoma
Therapies	Pembrolizumab + S095029
Age Groups:	senior \| adult
Covered Countries	USA \| ITA \| HUN \| FRA \| ESP \| DNK \| BEL \| AUT \| AUS